Diuretic drug: Spironolactone and fatty liver

| Fatty liver | News | Treatments

Diuretic drug: Spironolactone and fatty liver

A study shows spironolactone reduces fatty liver risk in patients with hypertension, lowering liver fat accumulation and slowing fibrosis progression.

| Autoinmune hepatitis | Diseases | News

Higher risk of autoimmune hepatitis after age 65

Autoimmune hepatitis incidence has increased notably in older adults, with higher prevalence and better treatment response, often presenting with milder symptoms.

| Health | News

New drugs for weight loss

Orforglipron, an oral GLP-1 small molecule, shows significant weight loss results and may become an alternative to injectable drugs like Ozempic or Wegovy.

| Hepatitis B | News | Treatments

New treatment for Hepatitis B

Hydronidone has demonstrated significant reversal of liver fibrosis in patients with chronic hepatitis B, offering a potential new therapeutic option.

| Fatty liver | News | Treatments

Controlled metabolic accelerator: new drug for treating fatty liver disease

HU6 is a novel oral drug that reduces liver fat and body weight through controlled metabolic acceleration, showing promising results in clinical trials compared to placebo.

| Diseases | Fatty liver | News

Fatty liver disease and alcohol tolerance

A large study shows that daily alcohol consumption, even in small amounts, worsens liver fibrosis in patients with metabolic liver disease.

| Fatty liver | News | Treatments

Vitamin E for fatty liver disease

A large study reveals that vitamin E can reduce liver fibrosis and improve liver health in patients, reinforcing its therapeutic value alongside diet and exercise.

| Autoinmune hepatitis | News | Treatments

Infliximab treatment for autoimmune hepatitis

Infliximab shows positive results in autoimmune hepatitis resistant to conventional therapies, improving liver function in most patients and representing a potential future treatment option.

| Fatty liver | Health | News

Menarche and fatty liver

Women with early menarche show a higher risk of fatty liver disease. Later onset lowers this risk, highlighting the importance of monitoring weight and liver health.

| Health | Healthy nutrition | News

New drug for the treatment of obesity

MariTide, a new drug for obesity, delivers significant weight loss with a single monthly injection, while also reducing blood pressure and glucose levels in patients.